Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$3,743,257
+$90,241 QoQ
Shares Held
23,885
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#315
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $337,469,957 across 15 Drug Manufacturers - General names. NVS ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
78,682 | $94,373,559 | |
| 2 | JNJ |
Johnson & Johnson
|
183,113 | $46,505,208 | |
| 3 | AMGN |
Amgen Inc
|
123,217 | $44,619,340 | |
| 4 | ABBV |
AbbVie Inc.
|
161,999 | $40,765,428 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
259,210 | $32,748,591 | |
| 6 | MRK |
Merck & Co., Inc.
|
184,897 | $23,759,264 | |
| 7 | PFE |
Pfizer Inc
|
809,970 | $19,504,077 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
254,808 | $14,682,036 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,743,257 | 23,885 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $3,653,016 | 23,915 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $3,064,298 | 22,226 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $4,724,874 | 36,844 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,597,774 | 37,995 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $4,106,365 | 36,835 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $3,359,822 | 34,527 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,894,117 | 33,856 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $3,481,880 | 32,706 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $2,992,632 | 30,938 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $3,129,666 | 30,996 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,102,553 | 30,459 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,069,076 | 30,414 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,857,520 | 31,060 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,862,488 | 31,553 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $2,518,819 | 33,138 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,931,415 | 34,679 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,165,318 | 36,072 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,433,677 | 27,823 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,245,024 | 27,452 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,946,869 | 32,298 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,871,273 | 33,590 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,673,232 | 38,899 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,405,614 | 39,163 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,505,827 | 40,140 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $3,406,916 | 41,321 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||